Oral Session 1-9A Malignant Lymphoma: Diagnosis/Comorbidity/Others

[OS1-9A-3] Clinical impact of antiviral prophylaxis on outcome of HBsAg-positive DLBCL in the rituximab era

Ilseung Choi¹, Nobuhiko Yamauchi², Dai Maruyama³, Yoshiko Atsuta⁴, Rika Sakai⁵, Kazuho Miyashita⁶, Yukiyoshi Moriuchi⁷, Hideki Tsujimura⁸, Nobuko Kubota⁹, Go Yamamoto¹⁰, Tadahiko Igarashi¹¹, Koji Izutsu³, Shinichiro Yoshida¹², Kensuke Kojima¹³, Toshiki Uchida¹⁴, Yoshiko Inoue¹⁵, Norifumi Tsukamoto¹⁶, Eiichi Otsuka¹⁷, Sachiko Suzuki¹⁸, Yoko Inaguma¹⁹, Satoshi Ichikawa²⁰, Hiroshi Gomyo²¹, Yoko Ushijima²², Kisato Nosaka²³, Miho Kurata⁴, Yasuhito Tanaka²⁴, Ryuzo Ueda²⁵, Masashi Mizokami²⁶, Shigeru Kusumoto²⁷ (1.Department of Hematology, National Hospital Organization Kyushu Cancer Center, 2.Department of Hematology, National Cancer Center East Hospital, 3.Department of Hematology, National Cancer Center Hospital, 4.Japanese Data Center for Hematopoietic Cell Transplantation, 5.Department of Hematology and Medical Oncology, Kanagawa Cancer Center, 6.Department of Hematology, Yokohama City University Medical Center, 7.Department of Hematology, Sasebo City General Hospital, 8.Division of Hematology-Oncology, Chiba Cancer Center, 9.Department of Hematology, Saitama Cancer Center, 10.Department of Hematology, Toranomon Hospital, 11.Department of Hematology, Gunma Prefectural Cancer Center, 12.Department of Hematology, National Hospital Organization Nagasaki Medical Center, 13.Division of Hematology, Respiratory Medicine and Oncology, Saga University, 14.Department of Hematology-Oncology, Japanese Red Cross Nagoya Daini Hospital, 15.Department of Hematology, National Hospital Organization Kumamoto Medical Center, 16.Department of Hematology, Gunma University Hospital, Maebashi, 17.Department of Hematology, Oita prefectural Hospital, 18.Department of Hematology, National Hospital Organization Hokkaido Cancer Center, 19.Division of Hematology, Fujita Health University, 20.Hematology and Rheumatology, Tohoku University Graduate School of Medicine, 21.Division of Hematology, Hyogo Cancer Center, 22.Hematology and Oncology, Nagoya University Graduate School of Medicine, 23.Department of Hematology, Rheumatology and Infectious diseases, Kumamoto University Hospital, 24.Department of Virology and Liver unit, Nagoya City University, 25.Department of Tumor Immunology, Aichi Medical University School of Medicine, 26.Genome Medical Sciences, National Center for Global Health and Medicine, 27.Department of Hematology and Oncology, Nagoya City University Hospital)